That's what it's all about, Immutep have been diligent on this in my opinion...
Data has lead to trials progressing, efficacy is apparent in proportional amounts, enough to
encourage further investment....
Unmet needs for cancer patients have been targeted, sound strategy with results looking promising...
Management have set this company up to take advantage of options in wanting markets, are we about
to see the rewards for their efforts?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.005(1.89%) |
Mkt cap ! $396.3M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 27.0¢ | 26.5¢ | $185.3K | 690.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 92193 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 134673 | 7 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |